Ramipril Improves Walking For People With PAD

Pain-free walking as well as length of walk both improved greatly in patients with claudication following treatment with the ACE blocker ramipril. The new study, published in JAMA, revealed pain-free walking rose by 60 percent on average and maximum walking time doubled following six months of treatment with the ACE inhibitor. Close to every secondary result also improved with ramipril versus placebo, such as functional areas of health-related quality of life and the ankle-brachial index (ABI) - an impairment scale for peripheral arterial disease (PAD)...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Vascular Source Type: news